Free Trial

Northern Trust Corp Acquires 85,660 Shares of Concentrix Co. (NASDAQ:CNXC)

Concentrix logo with Business Services background

Northern Trust Corp raised its position in Concentrix Co. (NASDAQ:CNXC - Free Report) by 21.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 492,219 shares of the company's stock after acquiring an additional 85,660 shares during the period. Northern Trust Corp owned about 0.76% of Concentrix worth $21,298,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. Fuller & Thaler Asset Management Inc. raised its holdings in Concentrix by 38.1% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 2,981,227 shares of the company's stock valued at $128,998,000 after acquiring an additional 823,228 shares in the last quarter. Pzena Investment Management LLC raised its holdings in Concentrix by 60.0% in the 4th quarter. Pzena Investment Management LLC now owns 2,349,599 shares of the company's stock valued at $101,667,000 after acquiring an additional 880,960 shares in the last quarter. Copeland Capital Management LLC raised its holdings in shares of Concentrix by 32.9% in the 4th quarter. Copeland Capital Management LLC now owns 1,333,206 shares of the company's stock worth $57,688,000 after buying an additional 329,831 shares in the last quarter. Lyrical Asset Management LP raised its holdings in shares of Concentrix by 3.4% in the 4th quarter. Lyrical Asset Management LP now owns 1,258,398 shares of the company's stock worth $54,451,000 after buying an additional 41,540 shares in the last quarter. Finally, First Trust Advisors LP raised its holdings in shares of Concentrix by 34.0% in the 4th quarter. First Trust Advisors LP now owns 649,755 shares of the company's stock worth $28,115,000 after buying an additional 164,906 shares in the last quarter. Institutional investors and hedge funds own 90.34% of the company's stock.

Insider Activity at Concentrix

In related news, Director Olivier Duha sold 29,444 shares of Concentrix stock in a transaction dated Tuesday, April 15th. The stock was sold at an average price of $48.52, for a total transaction of $1,428,622.88. Following the completion of the transaction, the director now owns 1,155,862 shares in the company, valued at approximately $56,082,424.24. This trade represents a 2.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Cormac J. Twomey sold 500 shares of Concentrix stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $50.70, for a total value of $25,350.00. Following the transaction, the executive vice president now owns 38,630 shares of the company's stock, valued at $1,958,541. The trade was a 1.28% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 30,444 shares of company stock valued at $1,481,628. 3.20% of the stock is owned by insiders.

Concentrix Stock Up 2.0%

Shares of CNXC traded up $1.08 during midday trading on Friday, hitting $56.22. The stock had a trading volume of 975,209 shares, compared to its average volume of 708,022. The company has a 50 day simple moving average of $49.78 and a two-hundred day simple moving average of $46.89. Concentrix Co. has a twelve month low of $36.28 and a twelve month high of $77.00. The firm has a market cap of $3.59 billion, a price-to-earnings ratio of 15.15, a price-to-earnings-growth ratio of 0.63 and a beta of 0.52. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.42 and a quick ratio of 1.42.

Concentrix (NASDAQ:CNXC - Get Free Report) last released its quarterly earnings results on Wednesday, March 26th. The company reported $2.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.58 by $0.21. Concentrix had a return on equity of 16.67% and a net margin of 2.61%. The firm had revenue of $2.37 billion for the quarter, compared to the consensus estimate of $2.37 billion. During the same quarter last year, the business posted $2.57 EPS. The company's revenue for the quarter was down 1.3% on a year-over-year basis. On average, analysts anticipate that Concentrix Co. will post 10.11 EPS for the current year.

Concentrix Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, May 6th. Investors of record on Friday, April 25th were given a $0.3328 dividend. This represents a $1.33 dividend on an annualized basis and a dividend yield of 2.37%. The ex-dividend date was Friday, April 25th. Concentrix's dividend payout ratio is currently 33.33%.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on CNXC. Bank of America increased their target price on Concentrix from $58.00 to $59.00 and gave the stock a "neutral" rating in a report on Thursday, March 27th. Barrington Research dropped their target price on Concentrix from $70.00 to $54.00 and set an "outperform" rating for the company in a report on Monday, March 24th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Concentrix presently has an average rating of "Buy" and a consensus target price of $65.75.

Read Our Latest Research Report on CNXC

About Concentrix

(Free Report)

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

Featured Articles

Institutional Ownership by Quarter for Concentrix (NASDAQ:CNXC)

Should You Invest $1,000 in Concentrix Right Now?

Before you consider Concentrix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.

While Concentrix currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines